Bucillamine

• CAT Number: R048457
• CAS Number: 65002-17-7
• Molecular Formula: C7H13NO3S2
• Molecular Weight: 223.305
• Purity: ≥95%
• Synonyms: N-(2-Mercapto-2-methyl-1-oxopropyl)-L-cysteine; N-(2-Mercaptoisobutyryl)cysteine; Rimatil; SA 96; Thiobutarit; Tiobutarit
• Target: VEGFR
• Storage: -20°C
• IUPAC Name: (2R)-2-[(2-methyl-2-sulfanylpropanoyl)amino]-3-sulfanylpropanoic acid
• InChI: InChI=1S/C7H13NO3S2/c1-7(2,13)6(11)8-4(3-12)5(9)10/h4,12-13H,3H2,1-2H3,(H,8,11)(H,9,10)/t4-/m0/s1
• InChIKey: VUAFHZCUKUDDBC-BYPYZUCNSA-N
• SMILES: CC(C)(C(=O)NC(CS)C(=O)O)S

Bucillamine is a synthetic derivative of cysteine with potent antioxidant and immunomodulatory properties. It has been widely used in the treatment of rheumatoid arthritis due to its ability to reduce inflammation and protect against oxidative damage. Bucillamine’s mechanism involves the modulation of immune responses and the scavenging of free radicals, making it effective in slowing disease progression. Recently, it has gained interest in clinical research for its potential to mitigate complications related to oxidative stress, including in viral infections and other inflammatory conditions. Its versatility makes Bucillamine a promising therapeutic candidate in various medical fields.